References
- BoehnckeWHEtiology and pathogenesis of psoriasisRheum Dis Clin North Am20154166567526476225
- QueiroRTejónPAlonsoSCotoPAge at disease onset: a key factor for understanding psoriatic diseaseRheumatology2014531178118524273020
- HuertaCRiveroERodríguezLAIncidence and risk factors for psoriasis in the general populationArch Dermatol20071431559156518087008
- KimGESeidlerEKimballABA measure of chronic quality of life predicts socioeconomic and medical outcomes in psoriasis patientsJ Eur Acad Dermatol Venereol20152924925424684416
- Ayala-FontánezNSolerDCMcCormickTSCurrent knowledge on psoriasis and autoimmune diseasesPsoriasis: Targets Ther20166732
- Ravi KanthVVNageshwar ReddyDRole of matrix metalloproteinases in physiological processes & diseaseIndian J Med Res201414058558725579138
- MooreCSCrockerSJAn alternate perspective on the roles of TIMPs and MMPs in pathologyAm J Pathol2012180121622033229
- VaskuVBienertova VaskuJSlonkováVMatrix metalloproteinase-2 promoter variability in psoriasisArch Dermatol Res200930146747319360430
- MezentsevANikolaevABruskinSMatrix metalloproteinases and their role in psoriasisGene201454011024518811
- NagaseHWoessnerJFMatrix metalloproteinasesJ Biol Chem1999274214912149410419448
- GiannelliGErriquezRFransveaEProteolytic imbalance is reversed after therapeutic surgery in breast cancer patientsInt J Cancer200410978278514999790
- RaczEPrensEPPhototherapy and photochemotherapy for psoriasisDermatol Clin201533798925412785
- FredrikssonTPetterssonUSevere psoriasis oral therapy with a new retinoidDermatologica1978157238244357213
- LipkaDBoratyńskiJMetalloproteinases: structure and functionPostepy Hig Med Dośw200762328336 Polish
- FinkKBoratyńskiJThe role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesisPostepy Hig Med Dośw201266609628 Polish
- Olewicz-GawlikAHrycajPŁąckiJKMetalloproteinases in the pathogenesis of systemic inflammatory rheumatic diseasesRu200543280285
- MieszałoKŁawickiSSzmitkowskiMThe utility of metalloproteinases (MMPs) and their inhibitors (TIMPs) in diagnostics of gynecological malignanciesPol Merkur Lekarski201640193197 Polish27088204
- GiannelliGErriquezRIannoneFMarinosciFLapadulaGAntonaciSMMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritisClin Exp Rheumatol20042233533815144129
- Guinea-ViniegraJZenzRScheuchHTNFalpha shedding and epidermal inflammation are controlled by Jun proteinsGenes Dev2009232663267419933155
- HeidenreichRRöckenMGhoreschiKAngiogenesis drives psoriasis pathogenesisInt J Exp Pathol20099023224819563608
- EysteinsdóttirJHSigurgeirssonBÓlafssonJHThe role of Th17/Tc17 peripheral blood T cells in psoriasis and their positive therapeutic responseScand J Immunol20137852953724111693
- FelicianiCVitulloPD’oraziGThe 72-kDa and the 92-kDa gelatinases, but not their inhibitors TIMP-1 and TIMP-2, are expressed in early psoriatic lesionsExp Dermatol199763213279412821
- SidhomEPilmaneMKisisJThe distribution of matrix metalloproteinase-2, tissue inhibitor of metalloproteinase-2 and tissue inhibitor of metalloproteinase-4 in psoriatic skinBr J Med Med Res20158883890
- FleischmajerRKurodaKHazanRBasement membrane alterations in psoriasis are accompanied by epidermal overexpression of MMP-2 and its inhibitor TIMP-2J Invest Dermatol200011577177711069613
- GuanQXiongZGLiHJSerum concentration of MMP-2, MMP-9, and IL-18 in the patients with Psoriasis Vulgaris and its clinical significanceChin J Lab Diag20127011
- FlisiakIPorebskiPChodynickaBEffect of psoriasis activity on metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in plasma and lesional scalesActa Derm Venereol200686172116585983
- AltrichterSBoodsteinNMaurerMMatrix metalloproteinase-9: a novel biomarker for monitoring disease activity in patients with chronic urticaria patients?Allergy20096465265619317840
- ChandranYCookRJEdwinJSoluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritisRheumatology (Oxford)2010491399140520421218
- GronskiTJMartinRLKobayashiDKHydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastaseJ Biol Chem199727212189121949115292
- RundhaugJEMatrix metalloproteinases and angiogenesisJ Cell Mol Med2005926728515963249
- YooSYKwonSMAngiogenesis and its therapeutic opportunitiesMediators Inflamm20132013e127170
- Stetler-StevensonWGSeoDWTIMP-2: an endogenous inhibitor of angiogenesisTrends Mol Med2005119710315760767
- ReichAMędrekKEffects of narrow band UVB (311 nm) irradiation on epidermal cellsInt J Mol Sci2013148456846623594996
- RáczEPrensEPKurekDEffective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathwaysJ Invest Dermatol20111311547155821412260
- RichardEGHönigsmannHPhototherapy, psoriasis, and the age of biologicsPhotodermatol Photoimmunol Photomed2014303724313462
- FuMinLXueWXiLingDAction mechanism of narrow-band ultraviolet B on vascular regulatory factors in psoriasis vulgarisChin J Dermatol200942163166
- FlisiakIMyśliwiecHChodynickaBEffect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1J Eur Acad Dermatol Venereol20051941842115987285
- WolkKWitteEWallaceEIL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasisEur J Immunol2006361309132316619290